A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Eli Lilly and Company
Eli Lilly and Company
University Hospital, Basel, Switzerland
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Nova Laboratories Limited
Cancer Research UK
Children's Oncology Group
Celgene
New Approaches to Neuroblastoma Therapy Consortium
National Institutes of Health Clinical Center (CC)
Sanofi
United Therapeutics
Duke University
Duke University
University of Kentucky
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital